The hypoxia-inducible transcription factor HIF-1 is appreciated as a promising target for cancer therapy. However, conditional deletion of HIF-1 and HIF-1 target genes in cells of the tumor microenvironment can result in accelerated tumor growth, calling for a detailed characterization of the cellular context to fully comprehend HIF-1's role in tumorigenesis. We dissected cell type-specific functions of HIF-1 for intestinal tumorigenesis by lineage-restricted deletion of the Hif1a locus. Intestinal epithelial cell-specific Hif1a loss reduced activation of Wnt/β-catenin, tumor-specific metabolism and inflammation, significantly inhibiting tumor growth. Deletion of Hif1a in myeloid cells reduced the expression of fibroblast-activating factors in tumor-associated macrophages resulting in decreased abundance of tumor-associated fibroblasts (TAF) and robustly reduced tumor formation. Interestingly, hypoxia was detectable only sparsely and without spatial association with HIF-1α, arguing for an importance of hypoxia-independent, i.e., non-canonical, HIF-1 stabilization for intestinal tumorigenesis that has not been previously appreciated. This adds a further layer of complexity to the regulation of HIF-1 and suggests that hypoxia and HIF-1α stabilization can be uncoupled in cancer. Collectively, our data show that HIF-1 is a pivotal pro-tumorigenic factor for intestinal tumor formation, controlling key oncogenic programs in both the epithelial tumor compartment and the tumor microenvironment.
Introduction
Colorectal cancer (CRC) ranks as the fourth most common tumor in the western world, causing a substantial amount of cancer-associated morbidity and mortality [1] . The combination of molecular-targeted drugs with conventional chemotherapeutic agents significantly improved the therapeutic options for CRC patients [2] . However, as also noted frequently for other solid tumors, these new generation treatments rarely result in improved overall outcome, but rather benefit small subgroups of CRC patients [3] . Taken together, an urgent need to identify novel therapy targets exists, demonstrating the necessity for detailed characterization of the molecular CRC pathogenesis.
The hypoxia-inducible transcription factor 1 (HIF-1) is positively associated with the malignant progression of various tumor entities [4] . While the role of HIF-1 for the pathogenesis of CRC has been addressed by different groups, results are conflicting and the precise function of HIF-1 for intestinal tumorigenesis remains elusive. Stabilization of HIF-1α, the regulatory component of HIF-1, in human CRC has been reported via immunohistochemistry, suggesting a pro-tumorigenic function [5] [6] [7] . In line with these findings, inhibition of HIF-1α in human CRC cell lines resulted in reduced xenograft growth [8, 9] . Furthermore, pharmaceutical inhibition of HIF-1 led to diminished growth of autochthonous as well as allograft murine CRC models via reduced angiogenesis and macrophage These authors contributed equally: Sandra Jumpertz, Merve Erdem infiltration [10] . On the other hand, transgenic activation of HIF-1 in intestinal epithelial cells (IEC) remained without effect on tumor formation in murine models of sporadic and colitis-associated colon cancer [11, 12] . Moreover, IECspecific loss of Hif1a did not affect tumor frequency in a chemical model of proximal intestinal tumorigenesis [13] . These results illustrate that the precise role of HIF-1 for intestinal tumorigenesis remains elusive thus far.
While HIF-1 is widely appreciated as a promising target for cancer therapy, conditional deletion of HIF-1 and HIF-1 target genes in cells of the tumor microenvironment can result in accelerated tumor growth [14] [15] [16] . Against this background, a comprehensive analysis of HIF-1's role in tumorigenesis in order to translate the findings into the clinic can only be achieved by considering the cell-and tissue-specific context. Here, we present a detailed deconstruction of HIF-1's role in CRC initiation and progression in IEC-and myeloid cell-specific Hif1a knock-out mice [17, 18] using two murine models of intestinal tumor formation: chemically induced colon tumors (AOM/DSS (combination of azoxymethane plus dextran sulfate sodium for colitisassociated carcinogenesis) [19] ) and the genetic APC min model [20] . This experimental approach enabled us to address the role of HIF-1 in neoplastic epithelial cells as well as in innate immune cells of the tumor microenvironment. We were able to unravel numerous specialized functions of HIF-1. In IECs, HIF-1 serves to induce inflammation, control Wnt/β-catenin activity and regulate tumor-specific metabolism. In addition, we identified myeloid HIF-1 as essential for the activation of tumorassociated fibroblasts. Of note, intratumoral hypoxia was a rare event, pointing toward an importance of hypoxiaindependent, i.e., non-canonical HIF-1 stabilization for intestinal tumorigenesis [21] . Collectively, our data show that HIF-1 is a pivotal pro-tumorigenic factor, controlling key oncogenic programs in both the epithelial tumor compartment and the tumor microenvironment.
Results
Epithelial Hif1a controls intestinal tumor growth on multiple levels IEC-specific loss of Hif1a (termed Hif1a IEC ) was established by breeding villin-cre mice [22] with animals harboring homozygously floxed Hif1a alleles [18] . Conditional Hif1a deletion was characterized on various levels and found to be highly efficient ( Figure S1A ). Tumor size in both the AOM/DSS and APC min model was significantly decreased in Hif1a IEC mice (Fig. 1a) . While proliferation was not different between the genotypes (data not shown), Hif1a IEC adenomas displayed significant differences regarding the number of apoptotic tumor cells ( Figure S1B ) and CD31-positive endothelial cells as well as Vegfa expression ( Figure S1C ), pointing toward a functional importance of HIF-1α in tumor cells for resistance toward apoptosis and angiogenesis. To further analyze the mechanisms underlying the reduced tumor size in Hif1a IEC mice, we first characterized the activity of the Wnt/β-catenin pathway, the central oncogenic driver of CRC. As can be seen in Fig. 1b-d , the expression of selected β-catenin target genes is significantly reduced in adenomas of Hif1a IEC mice. Of note, nuclear translocation of β-catenin was not affected by the Hif1a KO ( Figure S1D) . Furthermore, the expression of TCF-1 and LEF-1, two pivotal binding partners for β-catenin that have been characterized as HIF-1 targets by the group of Celeste Simon in murine embryonic stem and teratocarcinoma cells [23] was independent of HIF-1 in murine intestinal adenomas ( Figure S1E ). While these results strongly suggest a functional role of HIF-1 for Wnt/β-catenin activity in murine intestinal tumorigenesis, the underlying molecular mechanisms remain elusive at this point. Next, we addressed the role of Hif1a for tumorspecific glucose metabolism as metabolic reprogramming represents an emerging hallmark of cancer and several glycolytic enzymes are transcriptionally controlled by HIF-1 [24] . Mass spectrometry-based analysis of intratumoral glucose levels, routing of 13 C-labeled glucose as well as in vivo imaging by PET/CT revealed diminished uptake and metabolization into lactate of glucose in tumors of Hif1a IEC mice (Fig. 1e, f) . Finally, we performed a comprehensive analysis of inflammatory activity as chronic inflammation is pro-tumorigenic in CRC [25] . Hif1a IEC mice displayed reduced loss of body weight (Fig. 2a) and colitis activity after DSS challenge (Fig. 2b) . Intestinal gene expression and protein secretion of pro-inflammatory factors were significantly lower in DSS-treated Hif1a IEC mice (Fig. 2c, d ). We included a characterization of mucins as these evolutionary preserved glycoproteins are of crucial importance for innate immune responses in the gut [26] . As Muc1, 2 and 3 can be regulated by HIF-1 [27] [28] [29] , we investigated their gene expression patterns and found no difference under basal conditions. In contrast, Muc1 and 3 were strongly upregulated by DSS in a HIF-1α-dependent manner ( Figure S2A ). Quantification of the inflammatory infiltrate via immunohistochemistry did not show significantly reduced numbers of macrophages, granulocytes, T cells and Tregs after DSS in the colon of Hif1a IEC animals ( Figure S2B ). This at first surprising result is in line with published findings demonstrating that clinical and biochemical inflammation markers do not necessarily overlap with the cellular infiltrate in the DSS model [30] . Experiments with small intestinal organoids were conducted to further address the specific contribution of IECs in this setting. After assuring efficient Hif1a deletion ( Figure S2C ), organoids were subjected to different pro-inflammatory stimuli. These experiments nicely confirmed that the proinflammatory response of IECs critically depends on Hif1a (Fig. 2e) . Taken together, these data point toward a complex role for Hif1a in IECs during intestinal tumor formation, comprising resistance to apoptosis, angiogenesis, Wnt/β- Hif1a in myeloid cells regulates intestinal tumor formation independent of inflammation Macrophages in the tumor microenvironment exert a number of tumor-supporting functions and are positively associated with the malignant phenotype [31] . We and others have shown that Hif1a is of pivotal importance for various aspects of macrophage function [17, 32] . Against this background, we sought to characterize the role of Hif1a in macrophages for intestinal tumor formation. We found that myeloid cell-specific loss of Hif1a (termed Hif1a MC ) resulted in a highly significant reduction of both tumor number and size (Fig. 3a) . In order to identify the underlying mechanisms, we first analyzed the inflammatory response. Rather unexpectedly, various assays of inflammation (e.g., determination of weight loss (Fig. 3b) , disease activity index (Fig. 3c) ) as well as gene expression and protein secretion of established pro-inflammatory markers ( Fig. 3d-f) ) failed to show a significant difference between wildtype and Hif1a MC mice.
Hif1a-deficient tumor-associated macrophages migrate and function normally
Next, we determined intratumoral macrophage numbers via immunohistochemistry (IHC). While macrophage abundance was clearly greater in adenomas compared to surrounding normal mucosa (not shown), no difference was detectable between the genotypes (Fig. 4a) . Intestinal leukocyte subsets were subsequently analyzed in more detail by flow cytometry. Tumor-bearing mice displayed a prominent increase in CD11c+ macrophages and CD11b+ dendritic cells, while CD11c− macrophages were reduced. The changes in myeloid subsets were comparable between wildtype and Hif1a MC mice, except for a slightly more pronounced reduction of CD11c− intestinal macrophages in tumor-bearing Hif1a MC mice (Fig. 4b) . Intestinal lymphoid cell populations did not differ significantly between wildtype and Hif1a MC mice (Fig. 4b) . Notably, tumorbearing animals showed typical alterations of extraintestinal myeloid cells [33] , including increase of monocytes in blood and bone marrow and accumulation of Gr1+ CD11b+ myeloid-derived suppressor cells (MDSCs) in bone marrow, but not spleen ( Figure S3 ). Extraintestinal myeloid cells did not differ between wildtype and Hif1a MC mice. Next, we decided to analyze the direct tumor-supporting action of macrophages as these cells secrete numerous protumorigenic factors [34] . To this end, spheroids of APC min adenomas were stimulated with conditioned medium (CM) from primary murine macrophages. While we were able to detect a significant growth-promoting effect of macrophage CM, the loss of Hif1a did not affect the outcome (Fig. 4c) . As macrophages represent pivotal modulators of stem-like/ progenitor cells [35] , which are critical drivers of colonic carcinogenesis [36] , we decided to quantify these cells in our experimental setting. Visualization of Lgr5 and Prox1, two established progenitor/stem-cell markers in intestinal tumors [37, 38] , demonstrated robust presence of these cells in AOM/DSS adenomas, albeit without differences between the genotypes ( Figure S4A ). We took into consideration that other cells of myeloid origin might underlie the reduced tumor formation in Hif1a MC mice. While mast cells can influence intestinal tumorigenesis under certain experimental conditions [39] , no difference in intratumoral abundance of this cell type was noted, arguing against a functional importance of mast cells in our setting ( Figure  S4B ).
Hif1a in myeloid cells is essential for the activation of tumor-associated fibroblasts
Myeloid cells in the tumor microenvironment are known to interact with various cell types, including tumor-associated fibroblasts (TAF). These cells are abundant in human CRC and significantly impact on disease progression [40, 41] . TAFs were readily detectable via IHC in the stroma of APC min and AOM/DSS-induced adenomas (Fig. 5a ). Strikingly, deletion of Hif1a in myeloid cells resulted in greatly reduced numbers of TAFs in both tumor models (Fig. 5a ). This result pointed toward a crucial role of Hif1a in myeloid cells for TAF development. Interestingly, the importance of macrophages for fibroblast activation in the context of wound healing is well established [42, 43] . To analyze this further, we focussed on alternatively activated macrophages (AAM) given their central role in the control of organ fibrosis [42] . Expression of various pro-fibrotic genes in AAMs was readily detectable, but loss of Hif1a IEC mice on day 6 of acute DSS treatment (n = 5 per group). e Pro-inflammatory cytokine mRNA expression in small intestinal organoids from WT and Hif1a IEC mice. Shown are mean and standard deviation of technical duplicates from one representative experiment (no statistical analysis performed). Unless indicated otherwise, data are represented as mean + SEM. *p < 0.05; **p < 0.01; ***p < 0.001 by unpaired two-sided Student's t-test remained without greater effect ( Figure S5A ). To achieve experimental data that more closely resemble the in vivo situation, we analyzed pro-fibrotic factor expression in tumor-associated macrophages (TAM) directly isolated from intestinal adenomas. This approach indeed unraveled a central role of Hif1a in TAMs for the expression of various fibroblast-activating factors, e.g., COX-2, IGF-1, IL-1β and granulin (Fig. 5b) . In our analyses, the expression of TGF-β1, the archetypical pro-fibrotic factor, was constantly lower in Hif1a-null TAMs, but did not reach statistical MC mice on day 6 of acute DSS treatment (n = 5 per group). f Relative mRNA expression of inflammatory genes in intestinal tissues of WT and Hif1a
MC control (n = 3 biological replicates with technical duplicates) and APC min mice (n = 4 biological replicates with technical duplicates). Data are represented as mean + SEM. *p < 0.05; **p < 0.01 by unpaired two-sided Student's t-test significance (Fig. 5b) . As the activation of TGF-β1 is a complex and highly regulated process [44] , we hypothesized that HIF-1α is of importance in this setting. Indeed, HIF-1α-deficient AAMs displayed reduced levels of bioactive TGF-β in the supernatant (Fig. 5c) , suggesting a functional importance of HIF-1α for TGF-β activity elicited by TAMs. Next, we addressed the role of Hif1a for macrophage-mediated fibroblast proliferation [42, 45] . While conditioned medium from AAM enhanced survival of primary murine intestinal fibroblasts (MIFs), no difference between WT and Hif1a-deficient macrophages was detectable ( Figure S5B ). Finally, we sought to address the secretion of pro-tumorigenic cytokines, another tumorpromoting function of TAFs [46] . Stimulation of primary MIFs with conditioned medium from AAM induced gene expression of IL-6, HGF and epiregulin (Ereg), factors with established tumor-promoting activity in the intestine [47, 48] . Of note, this effect was significantly reduced upon deletion of Hif1a in macrophages (Fig. 5d) .
Myeloid-mediated activation of TAF precursor cells depends on Hif1a
TAFs can originate from different cellular sources, amongst others pericytes, mesenchymal stems cells (MSCs) and fibrocytes [46] . We sought to investigate if macrophages are able to polarize these cell types into myofibroblasts and whether Hif1a is important in this setting. Gli1-positive pericytes, marked by tdTomato expression [49] , as well as MSCs readily polarized into myofibroblasts after addition of macrophage conditioned medium (CM, Fig. 6a, b) . Intriguingly, HIF-1α was of central importance in this setting as the effect on pericytes was completely and that on MSCs partially abolished upon Hif1a deletion. Fibrocytes are of myeloid origin, display features of monocytes as well as fibroblasts and contribute to fibrosis in various organs and tumors [50, 51] . We took advantage of an established protocol to generate fibrocytes ex vivo from splenic monocytes [52] . Of note, Hif1a-deficient monocytes displayed greatly reduced capacity for fibrocyte production (Fig. 6c) . Furthermore, the expression of various tumorsupporting factors in fibrocytes was found to be regulated by Hif1a (Fig. 6d) . Taken together, these results point to a hitherto unknown function of Hif1a for the activation of TAF precursor cells of different origin.
Non-canonical stabilization of HIF-1α predominates in murine intestinal tumors
The luminal cell layer of the colon is characterized by physiological hypoxia [53] . Nuclear HIF-1α protein is readily detectable in luminal enterocytes ( Figure S6A ), suggesting hypoxia-induced HIF-1α protein stabilization in the gut under physiological conditions. Against this background, we sought to determine the relevance of hypoxia for HIF-1α protein stabilization in murine intestinal tumors. Intriguingly, hypoxic areas were detected only sporadically in AOM/DSS and APC min adenomas (Fig. 7a, b ). This pattern of hypoxia was clearly not able to explain the pervasive stabilization of HIF-1α protein in both tumor types. Of note, hypoxia-independent means of HIF-1α protein stabilization have been identified and are gradually receiving more attention [21, 24] . As activation of various oncogenes has been shown to result in hypoxia-independent HIF-1 stabilization [24] , we decided to investigate the role of oncogenes and tumor suppressor genes characteristic for colon cancer [54] . To mimic the molecular events that instigate tumor formation in the APC min model, mice with inducible Apc deletion were analyzed [55] . Of note, acute Apc loss resulted in enhanced HIF-1α protein stability (Fig. 7d) . To analyze the role of oncogene activation for HIF1a stabilization, we took advantage of transgenic mice with doxycycline-inducible, epithelial-specific expression of oncogenes with relevance for CRC pathogenesis [56, 57] . The strongest effect was noted for PIK3CA H1047R , the activation of which resulted in robust HIF-1α protein stabilization of the entire epithelial cell lining (Fig. 7e) . Induction of oncogenic KRAS G12V or degradation-resistant β-catenin resulted in localized HIF-1α stabilization in luminal epithelial cells (Fig.  7f, g ). These results point toward a functional role of key tumor suppressors and oncogenes regulating the Wnt/β-catenin, phosphatidylinositol-3-kinase and mitogen-activated protein kinase cascades for non-canonical HIF-1α stabilization during intestinal tumor formation and progression.
Discussion
Here, we addressed the functional importance of HIF-1 for colon cancer in a cell type-specific manner, using transgenic mice harboring either an intestinal epithelial cell-(Hif1a IEC ) or a myeloid cell-specific (Hif1a MC ) Hif1a deletion [17, 18, 22] . We found that Hif1a plays multiple non-redundant roles in these two key cell types of intestinal tumors (summarized in CT26 allografts [10] . Of note, transgenic overexpression of oxygen-stable HIF-1α in intestinal epithelial cells did not further accelerate the formation of AOM/DSS and APC min tumors [11] . Deletion of Hif1a in IECs did not affect tumor size in a chemical model of proximal colon cancer [13] , arguing for the importance of cell type-and locationspecific factors that need to be further investigated.
In our experiments, Hif1a IEC mice displayed lower levels of pro-inflammatory cytokines in acute DSS-induced colitis, suggesting an activating function of HIF-1 in IECs for intestinal inflammation. This result contrasts with earlier reports from various independent groups. Karhausen et al. noted enhanced activity in hapten-induced intestinal inflammation upon conditional loss of Hif1a in IECs [53] and identified reduced barrier integrity in mutant mice as the underlying mechanism. Against this background, we determined intestinal barrier function in our mice and could not find a difference between WT and Hif1a IEC mice ( Figure  S7 ). Later, Shah et al. reported no effect of IEC-specific Hif1a loss on the severity of acute DSS-induced colitis [58] . It is well established that the susceptibility to experimentally induced colitis is genetically determined and differs substantially between inbred strains of mice [59] . Karhausen et al. and Shah et al. used mice with a mixed genetic background while our mice were >99% C57Bl6/J, potentially explaining the different results. Additional support for a protective role of HIF-1 during intestinal inflammation came from two simultaneously published seminal reports by the groups of Sean Colgan and Cormac Taylor showing that inhibitors of prolyl hydroxylases (PHDs), a group of enzymes crucial for HIF degradation, protect against murine colitis [60, 61] . In our opinion, different explanations are possible regarding the conflict with our data, e.g., a functional importance of other PHD targets, e.g., NF-κB, and hydroxylase-independent functions of PHD inhibitors. Furthermore, systemically administered PHD inhibitors target every cell they encounter while in our genetic model HIF-1 was exclusively deleted in IECs, precluding a direct comparison of the different experimental approaches.
Regarding Hif1a in myeloid cells, we did not observe significant changes in DSS-induced intestinal inflammation and this is well in line with data from a Korean group [62] . On the contrary, Sandra Winning, Joachim Fandrey and colleagues reported protective roles for Hif1a in myeloid [63] and dendritic cells [64] upon DSS challenge. Of note, Kim et al. could not detect a functional importance of Hif1a in myeloid cells for AOM/DSS-induced tumor formation, clearly contrasting with our data [62] . The exact mechanisms for these opposing results remain elusive at this time.
Our analysis of mucin gene expression confirms earlier reports showing induction of mucin gene expression by DSS [65] and the notion that Muc1 and 3 are direct targets of HIF-1α [27, 29] . Complementing the published work, we were able to show that HIF-1α is essential for DSS-induced gene expression of Muc1 and 3 in murine intestinal eptithelial cells. In contrast, our results do not support a functional relevance of HIF-1α in IECs for basal expression of these mucin isoforms. Taken together, these data argue for a causal role of HIF-1-induced Muc1 and 3 for the inflammatory response to DSS, a notion well in line with the established importance of mucins for innate immunity [66] .
Seminal work in the laboratory of Randall Johnson had shown that HIF-1α is essential for myeloid cell-mediated inflammation and that Hif1a-deficient macrophages fail to migrate toward pro-inflammatory cues [17] . Our results contrast with this observation as we did not detect reduced macrophage abundance in tumors of Hif1a MC mice. However, our data are well in line with a later study from the Johnson lab demonstrating no effect of the myeloid cellspecific Hif1a KO on the abundance of F4/80-positive macrophages in a murine breast cancer model [67] . The precise reason(s) for this discrepancy must remain elusive at this time, but context-and model-specific factors could well play a significant role. It is conceivable that infiltration of macrophages into tumors is not as sensitive to Hif1a deletion as tissue infiltration in the context of inflammation. In addition, it is possible that proliferation of local macrophages compensates for reduced macrophage infiltration into KO adenomas [68] . This would result in a situation where the findings by Cramer et al. [17] and Doedens et al. [67] would be well in line with our current data.
Our findings support a central role of HIF-1α in myeloid cells for the activation of fibroblasts in the stroma of intestinal tumors. In the context of wound healing and organ fibrosis, the importance of macrophages, especially that of alternatively activated macrophages (AAM), for fibroblast activation is well established [69, 70] . AAMs are of special significance as they express various fibroblast-activating factors [42] . While earlier reports showed a functional relevance of HIF-1 for the control of gene expression of pro-fibrotic factors (e.g., TGF-β1, endothelin-1, fibronectin-1 and COX-2 [71] [72] [73] [74] ) in different cell types, Hif1a deletion MC (n = 4 biological replicates with technical duplicates) mice. c Determination of bioactive TGF-β in the supernatant of alternatively activated WT and Hif1a KO macrophages (n = 3 per group). d Relative mRNA expression of pro-tumorigenic genes in primary murine intestinal fibroblasts stimulated with conditioned media from WT and Hif1a KO macrophages (n = 3 biological replicates with technical duplicates). Data are represented as mean + SEM. *p < 0.05, **p < 0.01 by unpaired two-sided Student's t test in AAMs remained without effect on mRNA expression of a comprehensive set of pro-fibrotic factors in our experimental setup. To address the importance of the tissue context, we isolated tumor-associated macrophages (TAMs) from intestinal adenomas. Of note, in these cells the expression of various pivotal pro-fibrotic genes was indeed regulated by Hif1a. These results not only underscore the significance of Hif1a for TAM-mediated activation of TAFs, but again illustrate the importance of experimental conditions that more closely resemble the tissue context. ;tdTomato mice and cultured with supernatants of CAM or AAM from either wildtype or Hif1a MC mice and stained for alpha smooth muscle actin (αSMA) indicating myofibroblast differentiation (n = 3 per group). b Mesenchymal stem cells were cultured in collagen gels for 14 days either in stem cell expansion medium (SCEM, control) or in a mixture of SCEM and supernatants of M0, CAM or AAM (n = 3 per group).
Collagen gel areas were measured using the ImageJ software. c Representative images of fibrocytes differentiated in vitro from splenic monocytes from WT and and Hif1a MC mice. Magnification ×25 (upper panel) and ×100 (lower panel). d Relative mRNA expression of selected pro-tumorigenic factors in differentiated fibrocytes from WT and and Hif1a MC mice (n = 3 biological replicates with technical duplicates). Data are represented as mean + SEM. *p < 0.05 by unpaired two-sided Student's t-test TAFs were for the longest time unequivocally considered to support tumor growth and progression [46] . This concept was recently challenged by reports from three independent groups, showing accelerated tumor progression upon either genetic ablation of αSMA-positive TAFs or attenuated stroma formation in murine pancreatic ductal adenocarcinoma [75, 76] . At first glance, this observation contrasts with our data arguing for a tumor-supporting role of TAFs. Besides cancer type-and context-specific factors, the different experimental approaches are strong candidates for potential explanations. The group of Raghu Kalluri used an elegantly designed genetic model resulting in direct ablation of TAFs. Our experimental setup, on the other hand, targeted TAFs indirectly via deletion of Hif1a in myeloid cells. The studies by Ozdemir et al. and Rhim et al. point toward previously unappreciated tumor-inhibiting functions of TAFs. How pro-and anti-tumor aspects of TAFs are regulated is an intriguing question. While our data suggest that myeloid Hif1a impacts mainly on tumor-supporting aspects of TAFs, future work has to address the eligibility of HIF-1 inhibitors in the setting of a stroma-targeting cancer therapy.
Our study highlights that HIF-1α can be stabilized by multiple means in the colon cancer context. We show that loss of APC, as well as oncogenic activation of PIK3CA or KRAS in intestinal epithelial cells is followed by HIF-1α stabilization. Our findings give credence to the concept of non-canonical HIF-1α stabilization that was recently coined by Amato Giaccia and colleagues [21] . It is important to note that we cannot exclude a role for hypoxia downstream of the genetic changes and that this study has not determined the exact molecular link(s) relaying oncogenic events to HIF-1α stabilization. However, our data add a further layer of complexity to HIF-1α regulation, and suggest that hypoxia and HIF-1α stabilization can be uncoupled in cancer.
Materials and methods

Animals and mouse models
In all experiments, male and female mice were divided randomly into homogeneous groups according to their weight, age and sex (VillinCre/Hif1a In the acute DSS model, 10-12-week-old mice received 2% DSS in the drinking water for 6 days and were sacrificed on the last day of DSS administration. In order to assess DSS colitis activity, body weight, stool consistency and the presence of occult or gross blood were determined and a scoring system was applied [77] . Spheroids of APC +/min mice were cultured as described [78] . Oncogeneinducible mice have been described before [56, 57] . For histology, small intestines and colons were removed, flushed with PBS, fixed in 10% neutral buffered formalin at 4°C overnight and paraffin-embedded. Experimentation and transgenic animal generation was approved by authorities in Berlin (Landesamt für Gesundheit und Soziales: G0004/07, G0185/09, G0143/14).
Isolation and stimulation of bone marrow-derived macrophages (BMDMs)
Bone marrow was collected from tibiae, femurs and humeri of 8-12 weeks old wildtype and Hif1a MC mice. After flushing out the marrow, red blood cells were lysed with ACK buffer and cells were seeded on plastic plates in RPMI supplemented with 10% FBS, 100 U penicillin/ml, 100 μg/ml streptomycin. Next day, non-attached cells were collected and cultured in RPMI supplemented with 20% FBS and 30% L929-conditioned medium for one week. Differentiated BMDMs were stimulated for 48 h with LPS (100 ng/ml, Sigma Aldrich) and γ-IFN (20 ng/ml) for classically activated (CAM) and with IL-4 (20 ng/ml, both from eBioscience) for alternatively activated macrophages (AAM). For RNA isolation, cells were harvested using TRIzol (Invitrogen) from M0 (non-polarized), CAM and AAM. To collect conditioned media from polarized macrophages, cells were extensively washed with PBS 48 h after stimulation and fresh media was added for an additional 24 h.
Flow cytometric analyses of murine leukocyte populations
Small intestine was rinsed thoroughly and incubated in buffer containing EDTA to remove the mucus. Cells were minced and digested with type IV collagenase (Cellsystems). Blood was taken from the right ventricle. Small intestine, blood, bone marrow, and spleen cells were subjected to red blood cell lysis using Pharm Lyse (BD Biosciences, San Jose, USA). Flow cytometric analysis was done as described in detail before [79] . Antibodies were purchased from eBioscience (F4/80, #25-4801-82, CD3e, #25-0031-82, CD4, #17-0042-82 and CD8a, #25-0081-82), BD Biosciences (CD45, #557659, CD11b, #550993, Ly6G, #551460, CD19, #551001, CD107a, #553793, NK1.1, #553165, Gr1, #552093 and I-A b , #553552) and Biolegend (CD11c, #117312 and CD103, #121420).
Statistical analysis
Sample sizes were determined according to our experience in previous experiments and no statistical methods were used for predetermination. All experimental samples were included in the final analyses. Unless indicated otherwise, all data were representative of at least two independent experiments and expressed as means + SEM. Before statistical analysis, data were checked for normal distribution (Shapiro Wilk test) and comparable variance (F-test for equality of variances for data with normal distribution). Comparisons between two groups of normally distributed data with equal variances were performed using the unpaired two-sided Student's t-test. Differences were considered statistically significant at p < 0.05. Sample size, statistical tests and p values are indicated in the figure legends. The asterisks in the graphs indicate statistically significant changes with p values: *p < 0.05, **p ≤ 0.01, and ***p ≤ 0.001. Statistical analysis was done using Prism 4.0 software (GraphPad Software, San Diego, CA, USA). discussions and to Ilia N. Buhtoiarov (Children's Hospital of New Jersey, USA), Glenn S. Belinsky, Daniel W. Rosenberg (University of Connecticut Health Center, Farmington, USA), and Takuji Tanaka (Gifu Municipal Hospital, Japan) for providing control reagents. We are grateful to Deborah Gumucio (University of Michigan, USA) for providing Villin-Cre mice. The excellent technical assistance of Birgit Bogdanoff and Simone Spiekermann is highly appreciated. Parts of this work were granted the "Best Poster Award" at the 2015 CELL symposium "Cancer, Inflammation and Immunity" in Sitges, Spain.
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